US EditionComic Book Teaches Philly’s Black Transgender Women About HIV Prevention
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Comic Book Teaches Philly’s Black Transgender Women About HIV Prevention
Key Takeaways: A new comic book educates Black transgender women in Philadelphia about PrEP, a medication that prevents HIV. A health expert at Temple University uses marketing techniques to encourage better health decisions. By understanding how people think and feel, researchers create tailored messages to improve health outcomes. A Comic Book with a Lifesaving Message In Philadelphia, a unique comic book is helping Black transgender women le…
The Food and Drug Administration of the United States (FDA) approved the preventive use of lenacapavir, a drug designed to reduce the risk of human immunodeficiency virus (HIV) infection. This decision positions lenacapavir as the first six-monthly injection with federal backing to prevent the transmission of the virus. This drug, developed by the pharmaceutical company Gilead Sciences, will be marketed under the name Yeztugo and will be given i…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
